Shares of Arecor Therapeutics plc (LON:AREC – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 50 ($0.63) and last traded at GBX 50 ($0.63), with a volume of 50543 shares changing hands. The stock had previously closed at GBX 51.50 ($0.65).
Arecor Therapeutics Stock Performance
The stock has a 50-day simple moving average of GBX 59.94 and a 200-day simple moving average of GBX 70. The company has a debt-to-equity ratio of 5.51, a current ratio of 1.37 and a quick ratio of 6.24. The stock has a market cap of £18.88 million, a PE ratio of -1.77 and a beta of -0.18.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- The Role Economic Reports Play in a Successful Investment Strategy
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- What Are Dividend Contenders? Investing in Dividend Contenders
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
